Clinical Trials Directory

Trials / Sponsors / Foresee Pharmaceuticals Co., Ltd.

Foresee Pharmaceuticals Co., Ltd.

Industry · 15 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingEffect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)
Asthma (Diagnosis), Pulmonary Function, Moderate-to-Severe Asthma
Phase 22026-01-01
WithdrawnEfficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate Cancer
Prostate Cancer
Phase 32025-07-01
WithdrawnEfficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer
Prostate Cancer
Phase 32025-06-01
RecruitingStudy to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD
Group 3 Pulmonary Hypertension
Phase 22025-03-01
CompletedSafety, Tolerability, and Pharmacokinetics, of Single and Multiple Ascending Doses of FP-020 in Healthy Adult
Healthy
Phase 12024-04-16
WithdrawnA Dose Escalation Study of FP-045 in Patients With Fanconi Anemia
Fanconi Anemia
Phase 1 / Phase 22023-06-30
Active Not RecruitingEfficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty
Puberty; Precocious, Central
Phase 32023-06-02
TerminatedA Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19
Severe to Critical COVID 19 With Associated ARDS
Phase 2 / Phase 32021-04-06
CompletedThe Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic
Asthma, COPD
Phase 22018-07-02
CompletedMultiple-Dose, Dose-Escalation Study to Evaluate the Safety/Tolerability and Pharmacokinetics of FP-045
Healthy Volunteers
Phase 12018-02-22
CompletedSafety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate C
Prostatic Neoplasms
Phase 32017-09-26
CompletedA Phase 1, Pharmacokinetics of the MMP-12 Inhibitor FP-025 After Multiple Oral Ascending Doses in Healthy Subj
Healthy
Phase 12017-07-21
CompletedOpen-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50
Prostatic Neoplasms
Phase 32016-02-01
CompletedPhase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers
Healthy
Phase 12015-06-01
CompletedSafety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carci
Prostatic Neoplasms
Phase 32014-08-01